Pediatr. praxi. 2016;17(1):52-55 | DOI: 10.36290/ped.2016.011

Late onset of inherited urea cycle disorder - ornithine transcarbamoylase deficiency

MUDr.Jan Papež1, doc.MUDr.Tomáš Honzík, Ph.D.2, MUDr.RNDr.Pavel Ješina, Ph.D.3, MUDr.Petr Jabandžiev1, MUDr.Jiří Štarha, Ph.D.1, doc.MUDr.Dagmar Procházková, Ph.D.1, prof.MUDr.Zdeněk Doležel, CSc.1
1 Pediatrická klinika FN Brno a LF MU Brno
2 Klinika dětského a dorostového lékařství VFN a 1. LF UK Praha
3 Ústav dědičných metabolických poruch VFN a 1. LF UK Praha

Ornithine transcarbamylase deficiency (OTCD) is the most frequent inherited urea cycle disorder. This inherited metabolic disorder

(IMD) has gonosomal recessive mode of inheritance and results from a deficiency of the mitochondrial enzyme ornithine transcarbamylase,

which catalyses the conversion of ornithine and carbamoyl phosphate to citruline. The cumulation of toxic ammonia

and other metabolites are the main cause of the earlier or later clinical manifestation of the disease. The authors present a case

report of a thirteen-month-old boy who was taken to hospital due to apathy, overall hypotonia and hyperammonemia. Subsequent

metabolic investigation showed the ornithine transcarbamylase deficiency that was confirmed at molecular genetic level.

Keywords: inherited metabolic disorder, ornithine transcarbamylase, urea cycle disorder, hyperammonemia, late onset form

Published: February 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Papež J, Honzík T, Ješina P, Jabandžiev P, Štarha J, Procházková D, Doležel Z. Late onset of inherited urea cycle disorder - ornithine transcarbamoylase deficiency. Pediatr. praxi. 2016;17(1):52-55. doi: 10.36290/ped.2016.011.
Download citation

References

  1. Keskinen P, Siitonen A, Salo M. Hereditary urea cycle diseases in Finland. Acta Paediatr 2008; 97: 1412-1419. Go to original source... Go to PubMed...
  2. Balasubramaniam S, Rudduck C, Bennetts B, Peters G, Wilcken B, Ellaway C. Contiguous gene deletion syndrome in a female with ornithine transcarbamylase deficiency. Mol Genet Metab 2010; 99(1): 34-41. Go to original source... Go to PubMed...
  3. Dionisi-Vici C, Rizzo C, Burlina AB, et al. Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey. J Pediatr 2002; 140: 321-327. Go to original source... Go to PubMed...
  4. Yamaguchi S, Brailey LL, Morizono H, Bale AE, Tuchman M. Mutations and polymorphisms in the human ornitine transcarbamylase (OTC) gene. Hum Mutat 2006; 27: 626-632. Go to original source... Go to PubMed...
  5. Summer M. Current strategies for the management of neonatal urea cycle disorders. J Pediatr 2001; 138(1): 30-39. Go to original source... Go to PubMed...
  6. Caldovic L, Abdikarim I, Narain S, Tuchman M, Morizono H. Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update. J Genet Genomics. 2015; 42(5): 181-194. Go to original source... Go to PubMed...
  7. Walker V. Ammonia toxicity and its prevention in inherited defects of the urea cycle. Diabetes Obes Metab 2009; 11(9): 823-835. Go to original source... Go to PubMed...
  8. Quental R, Azevedo L, Rubio V, Diogo L, Amorim A. Molecular mechanisms underlying large genomic deletion in urea ornithinetranscarbamylase (OTC) gene. Clin Genet 2009; 75: 457-464. Go to original source... Go to PubMed...
  9. Kölker S, Cazorla AG, Valayannopoulos V, et al. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab Dis 2015; 1-17. Go to original source... Go to PubMed...
  10. Mathias RS, Kostiner D, Packman S. Hyperammonemia in urea cycle disorders: role of the nephrologist. Am J Kidney Dis 2001; 37(5): 1069-1080. Go to original source... Go to PubMed...
  11. Haeberle J, Boddaert N, Burlina A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis 2012; 29-32. Go to original source... Go to PubMed...
  12. Enns GM, Berry SA, Berry GT, Rhead WJ, Brusilow SW, Hamosh A. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med 2007; 356: 2282-2292. Go to original source... Go to PubMed...
  13. Brusilow SW. Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis. J Clin Invest 1984; 74: 2144-2148. Go to original source... Go to PubMed...
  14. Berry GT, Steiner RD. Long-term management of patients with urea cycle disorders. J Pediatr 2001; 138: S56-S61. Go to original source... Go to PubMed...
  15. Kölker S, Valayannopoulos V, Burlina AB, et al. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype. J Inherit Metab Dis 2015; 1-16.
  16. Campeau PM, Pivalizza PJ, Miller G, et al. Early orthotopic liver transplantation in urea cycle defects: follow up of a developmental outcome study. Mol Genet Metab 2010; 100(suppl 1): S84-S87. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.